Webinar
18.06.2026,
8:00 pm (UK)
Webinar for Medical Professionals:
Retrospective Evaluation Insights & 2026 Innovation Reveal
Join us for an exclusive educational webinar dedicated to MEC Regenerate®, a breakthrough regenerative concept based on collagen signalling stimulation and one of the most anticipated innovations of 2026.
During the session, Dr. Cemal Kavasogullari — currently participating in an ongoing international retrospective observation programme — will share his first-hand clinical insights, treatment observations, and practical experience related to this next-generation regenerative approach.
Designed to support skin regeneration through the activation of biological signalling pathways responsible for collagen renewal and tissue remodelling, MEC Regenerate® introduces a new perspective on advanced skin biostimulation and regenerative aesthetics.
Webinar Speaker:
Dr. Cemal Kavasogullari, MD, MRCGP, PGCert Aesthetic Medicine, PGCert Digital Health Systems
Dr. Cemal Kavasogullari, MD, MRCGP, PGCert Aesthetic Medicine, PGCert Digital Health Systems
The producer of MEC Regenerate is 303 Pharma, an Italian biotechnology company specializing in regenerative medicine and advanced aesthetic solutions. The company is globally recognized for developing Alpha-One Concept, a next-generation recombinant collagen derived from silkworm technology, designed to support tissue regeneration, skin rejuvenation, and cutting-edge aesthetic treatments.
“The Role of Biomimetic Signaling in the MEC Regenerate® Extracellular Matrix Regeneration System.”
A new approach to skin biostimulation supported by retrospective clinical observations gathered during the pre-market clinical evaluation phase of the product.
MEC Regenerate® is an advanced system designed to support extracellular matrix remodelling, which is currently undergoing the conformity assessment process in accordance with Regulation (EU) 2017/745 (MDR). The manufacturer, the Italian company 303Pharma, has launched a structured programme to collect real-world clinical evidence and conduct a multicentre observational evaluation aimed at supporting the clinical evaluation process for the device.
As part of this process, a retrospective observational study has been launched in Poland, United Kingdom and Italy.
Preliminary observations gathered during the evaluation indicate a favourable tolerability profile and a clinically appreciable improvement in certain parameters related to skin quality and tissue laxity in the middle and lower third of the face. The full results of the evaluation will be further developed and discussed in the context of the clinical evaluation activities currently underway.
Webinar Speaker:
Dr. Cemal Kavasogullari, MD, MRCGP, PGCert Aesthetic Medicine, PGCert Digital Health Systems
Dr. Cemal Kavasogullari is a medical doctor, international educator, and thought leader in aesthetic medicine, longevity, digital health, and medical leadership. He is Co-Founder and Medical Director of Esteem Life Medical Group, an award-winning clinic recognised for its innovative approach to aesthetic and longevity-focused care.
A graduate of Hacettepe University Faculty of Medicine, Dr. Kavasogullari has trained and worked within leading healthcare institutions in both Turkey and the United Kingdom, including University College London and St Bartholomew’s Hospital, gaining experience in head and neck surgery, breast surgery, primary care, and aesthetic medicine. He subsequently completed General Practice training in Glasgow and earned a Postgraduate Certificate in Aesthetic Medicine from Queen Mary University of London, followed by a Postgraduate Certificate in Digital Health Systems from the University of Strathclyde and an Executive Leadership Certificate from Babson College.
Internationally recognised for his educational contributions, Dr. Kavasogullari serves as a Masterclass Trainer for Beauty Europe, Global Faculty and Trainer for Alma Lasers UK & Ireland, National Trainer for VIVACY UK, Faculty Member and Speaker for SkinCeuticals UK. Alongside his clinical work, he is actively involved in medical education, research, healthcare innovation, and professional leadership. Dr. Kavasogullari regularly lectures at leading international conferences and educational forums, with particular interests in regenerative aesthetics, energy-based devices, combination treatment strategies, longevity medicine, and the integration of digital technologies into clinical practice.
A graduate of Hacettepe University Faculty of Medicine, Dr. Kavasogullari has trained and worked within leading healthcare institutions in both Turkey and the United Kingdom, including University College London and St Bartholomew’s Hospital, gaining experience in head and neck surgery, breast surgery, primary care, and aesthetic medicine. He subsequently completed General Practice training in Glasgow and earned a Postgraduate Certificate in Aesthetic Medicine from Queen Mary University of London, followed by a Postgraduate Certificate in Digital Health Systems from the University of Strathclyde and an Executive Leadership Certificate from Babson College.
Internationally recognised for his educational contributions, Dr. Kavasogullari serves as a Masterclass Trainer for Beauty Europe, Global Faculty and Trainer for Alma Lasers UK & Ireland, National Trainer for VIVACY UK, Faculty Member and Speaker for SkinCeuticals UK. Alongside his clinical work, he is actively involved in medical education, research, healthcare innovation, and professional leadership. Dr. Kavasogullari regularly lectures at leading international conferences and educational forums, with particular interests in regenerative aesthetics, energy-based devices, combination treatment strategies, longevity medicine, and the integration of digital technologies into clinical practice.
Who is this webinar for?
This webinar is dedicated to medical professionals who want to stay at the forefront of regenerative and aesthetic medicine and explore the latest innovations in collagen stimulation, skin regeneration, and longevity-focused treatment approaches.
What to expect?
Exclusive clinical observations and practical treatment insights shared directly from ongoing medical practice.
Introduction to the science of collagen signalling stimulation and the breakthrough regenerative concept behind MEC Regenerate.
Interactive Q&A session with Dr. Cemal Kavasogullari discussing protocols and observations.
What Makes MEC Regenerate®️ Different?
A New Approach to Biostimulation.
Built around recombinant biomimetic technology using the alpha-1 chain of Type I collagen, MEC Regenerate®️ acts as a biostimulant rather than a bio-irritant.
Instead of relying on inflammation to trigger collagen production, it is designed to support the skin’s natural regenerative processes through biomimetic signalling within the extracellular matrix.
A Four-Component Regenerative System. MEC Regenerate®️ combines four complementary components that work together in a coordinated sequence, supporting tissue quality, collagen organisation, and long-term skin health.
The Future of Regenerative Aesthetics. As aesthetic medicine evolves beyond volumisation and inflammation-based stimulation, a new generation of regenerative treatments is emerging, focused on biomimetic signalling, tissue quality, and long-term skin health.
Join us to explore how MEC Regenerate®️ is helping shape this shift in treatment philosophy and discover why clinicians around the world are beginning to embrace a more natural, biologically guided approach to skin regeneration.
Instead of relying on inflammation to trigger collagen production, it is designed to support the skin’s natural regenerative processes through biomimetic signalling within the extracellular matrix.
A Four-Component Regenerative System. MEC Regenerate®️ combines four complementary components that work together in a coordinated sequence, supporting tissue quality, collagen organisation, and long-term skin health.
The Future of Regenerative Aesthetics. As aesthetic medicine evolves beyond volumisation and inflammation-based stimulation, a new generation of regenerative treatments is emerging, focused on biomimetic signalling, tissue quality, and long-term skin health.
Join us to explore how MEC Regenerate®️ is helping shape this shift in treatment philosophy and discover why clinicians around the world are beginning to embrace a more natural, biologically guided approach to skin regeneration.
18/06/2026 (Thursday), 8:00 pm
We look forward to seeing you on Zoom!
After registering via Zoom, you will receive a link to the webinar room where the session will take place. If you do not receive the email with the webinar access link, please contact:
marketing@beautyeurope.eu